Phathom Pharmaceuticals, Inc. (PHAT)

NASDAQ: PHAT · Real-Time Price · USD

14.58

-0.12 (-0.82%)

Dec 5, 2025, 4:00 PM EST - Market closed

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Vonoprazan	55.25M	Log In
Vonoprazan Growth	8001.47%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	55.25M	Log In
United States Growth	8001.47%	Log In